Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
株式のランク #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
株価
$0.6
最終同期: 2024-08-14
時価総額
$2.09M
変化(1日)
0.00%
変化(1年)
0.00%
SG
取引 ASLAN Pharmaceuticals Limited (ASLN)

カテゴリー

ASLAN Pharmaceuticals Limited(ASLN)の株式分割履歴
ASLAN Pharmaceuticals Limited株(シンボル:ASLN)は合計で2回の株式分割を実施しました。
最新の株式分割はJul 03, 2024に行われました。
Mar 13, 2023より前に購入されたASLN株は、現在0.025ASLN株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2024-07-03 1:8 x0.125 x0.025
2023-03-13 1:5 x0.2 x0.2
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE